Eligibility Type 2 Diabetes NCT01153516

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
volunteers that are planned to undergo rygb(roux-en-y by pass) and have type 2 diabetes diagnosed within the prior 10 years.
Descrizione

Roux-en-Y Anastomosis Planned | Non-Insulin-Dependent Diabetes Mellitus Disease length

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0002804
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0011860
UMLS CUI [2,2]
C0872146
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
abnormal renal function
Descrizione

Abnormal renal function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151746
significant anemia
Descrizione

Anemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002871
difficult venous access
Descrizione

Poor venous access

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0577866
treatment with incretin mimetics or dpp iv inhibitors in the prior 3 months
Descrizione

Incretin mimetic therapy | Dipeptidyl-Peptidase IV Inhibitors

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3839883
UMLS CUI [2]
C1827106
recent change in use of any pharmacologic agent with potential effect on either beta-cell function or insulin resistance.
Descrizione

Change of medication Effect Beta Cell function | Change of medication Effect Insulin Resistance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0580105
UMLS CUI [1,2]
C1280500
UMLS CUI [1,3]
C0030281
UMLS CUI [1,4]
C0031843
UMLS CUI [2,1]
C0580105
UMLS CUI [2,2]
C1280500
UMLS CUI [2,3]
C0021655
pregnancy
Descrizione

Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
non -english speakers
Descrizione

Lacking Able to speak English Language

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C0564215
UMLS CUI [1,3]
C0376245

Similar models

Eligibility Type 2 Diabetes NCT01153516

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Roux-en-Y Anastomosis Planned | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
volunteers that are planned to undergo rygb(roux-en-y by pass) and have type 2 diabetes diagnosed within the prior 10 years.
boolean
C0002804 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Abnormal renal function
Item
abnormal renal function
boolean
C0151746 (UMLS CUI [1])
Anemia
Item
significant anemia
boolean
C0002871 (UMLS CUI [1])
Poor venous access
Item
difficult venous access
boolean
C0577866 (UMLS CUI [1])
Incretin mimetic therapy | Dipeptidyl-Peptidase IV Inhibitors
Item
treatment with incretin mimetics or dpp iv inhibitors in the prior 3 months
boolean
C3839883 (UMLS CUI [1])
C1827106 (UMLS CUI [2])
Change of medication Effect Beta Cell function | Change of medication Effect Insulin Resistance
Item
recent change in use of any pharmacologic agent with potential effect on either beta-cell function or insulin resistance.
boolean
C0580105 (UMLS CUI [1,1])
C1280500 (UMLS CUI [1,2])
C0030281 (UMLS CUI [1,3])
C0031843 (UMLS CUI [1,4])
C0580105 (UMLS CUI [2,1])
C1280500 (UMLS CUI [2,2])
C0021655 (UMLS CUI [2,3])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Lacking Able to speak English Language
Item
non -english speakers
boolean
C0332268 (UMLS CUI [1,1])
C0564215 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,3])